This Week Health
Alex's Lemonade Stand This Week Health
<- Back to Insights
February 13, 2024

23andMe’s Fall From $6 Billion to Nearly $0

WSJ
|
Summary
23andMe, once valued at $6 billion, now risks Nasdaq delisting with valuation down 98%, under $1 stock; CEO Wojcicki's billions lost; staff reduced 25% via layoffs, subsidiary sale; company unprofitable, may exhaust cash by 2025.

Explore Related Topics

Subscribe Now to Receive Seven Top Stories Daily to Your Inbox

Subscribe News
Healthcare Transformation Powered by Community

© Copyright 2024 Health Lyrics All rights reserved